A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Live Attenuated Varicella Vaccine in Healthy People
Latest Information Update: 20 Jun 2023
At a glance
- Drugs Live-attenuated-varicella-vaccine-China-National-Biotec-Group-Company (Primary)
- Indications Varicella zoster virus infections
- Focus Registrational; Therapeutic Use
- Sponsors China National Biotec Group
Most Recent Events
- 15 Jun 2023 Status changed from recruiting to active, no longer recruiting.
- 18 Jan 2023 Status changed from not yet recruiting to recruiting.
- 06 Jan 2023 New trial record